Truvestments Capital LLC Global Blood Therapeutics, Inc. Transaction History

Truvestments Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$22.3 - $37.39 $6,690 - $11,217	300 New	300 $10,000
Q1 2022 May 02, 2022	SELL	$25.68 - $35.59 $12,531 - $17,367	-488 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$32.46 - $43.42 $12,172 - $16,282	-375 Reduced 43.45%	488 $17,000
Q1 2021 May 18, 2021	SELL	$38.94 - $50.85 $2,414 - $3,152	-62 Reduced 6.7%	863 $35,000
Q4 2020 Feb 17, 2021	BUY	$37.65 - $63.77 $34,826 - $58,987	925 New	925 $40,000
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $48,803 - $68,903	-925 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$41.72 - $87.2 $38,591 - $80,660	925 New	925 $47,000
Q4 2019 Jan 29, 2020	SELL	$45.7 - $81.86 $42,272 - $75,720	-925 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$45.35 - $57.91 $13,605 - $17,373	300 Added 48.0%	925 $45,000
Q1 2019 Apr 12, 2019	SELL	$39.99 - $53.48 $1,319 - $1,764	-33 Reduced 5.02%	625 $33,000
Q3 2018 Oct 22, 2018	BUY	$38.0 - $51.1 $25,004 - $33,623	658 New	658 $25,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.